Multi-center study to evaluate the efficacy and to standardize RFA for early breast cancer

Multi-center study to evaluate the efficacy and to standardize RFA for early breast cancer - Multi-center study of RFA for early breast cancer

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000008675

Enrollment

372

Registered

2012-08-19

Start date

2013-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early breast cancer

Interventions

Radiofrequency ablation therapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Ductal carcinoma ( Invasive or non-invasive) diagnosed by core-needle biopsy T<=1.5cm on MMG, ultrasonography and MRI cN0

Exclusion criteria

Exclusion criteria: PH of other malignat disease within 5 years pregnancy severe complication on heart and brain disorder of blood coagulation multiple lesions lesions with EIC simulateneous bilateral breast cancer prior systemic therapy or radiotherapy to breast

Design outcomes

Primary

Measure	Time frame
5 years ipsilateral breast cancer recurennce rate	—

Secondary

Measure	Time frame
OS, DFS, AE, Imcomplete abtaion rate	—

Countries

Japan

Contacts

Public ContactSota Asaga

National Cancer Center Hospital Division of Breast Surgery

soasaga@ncc.go.jp0335422511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026